Media coverage
18
Media coverage
Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Morningstar.com Country/Territory United States Date 4/10/21 URL https://www.morningstar.com/news/globe-newswire/8336315/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundations-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepatitis-nash Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 4/10/21 Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet BioSpace Country/Territory United States Date 4/10/21 URL https://www.biospace.com/article/releases/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundation-s-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepatitis-nash-/?s=95 Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Yahoo! News Country/Territory United States Date 4/10/21 URL https://www.yahoo.com/now/madrigal-pharmaceuticals-announces-support-fatty-105000679.html Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet ADVFN UK Country/Territory United Kingdom Date 4/10/21 URL https://uk.advfn.com/stock-market/NASDAQ/MDGL/share-news/Madrigal-Pharmaceuticals-Announces-Support-of-Fatt/86202517 Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Yahoo! Canada Country/Territory Canada Date 4/10/21 URL https://ca.sports.yahoo.com/news/madrigal-pharmaceuticals-announces-support-fatty-105000679.html Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Yahoo! Finanzas Country/Territory United States Date 4/10/21 URL https://es-us.finanzas.yahoo.com/news/madrigal-pharmaceuticals-announces-support-fatty-105000679.html Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Chase Country/Territory United States Date 4/10/21 URL https://idc.chase.com/newspublic/story?article=233790e27069253b&controller=newspublic&action=search&module=default Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis Media name/outlet TD Ameritrade Country/Territory United States Date 4/10/21 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-277u0231 Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Market Newsdesk Country/Territory United States Date 4/10/21 URL https://www.marketnewsdesk.com/index.php/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundations-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepa/ Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation ’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Stockwatch Country/Territory Canada Date 4/10/21 URL www.stockwatch.com/News/Item/U-z8336315-U!MDGL-20211004/U/MDGL Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet ADVFN US Country/Territory United States Date 4/10/21 URL https://www.advfn.com/p.php?pid=nmona&article=86202517 Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet Crwe World Country/Territory United States Date 4/10/21 URL crweworld.com/article/news-provided-by-globenewswire/2149602/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundations-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepatitis-nash Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet WVB Country/Territory United States Date 4/10/21 URL wvb.com/news/industry/view/id/10236325 Persons Meena Bansal Title Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steatohepatitis (NASH) Media name/outlet Market News Publishing Country/Territory United States Date 4/10/21 Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet GlobeNewswire Country/Territory United States Date 4/10/21 URL https://www.globenewswire.com/news-release/2021/10/04/2307718/0/en/Madrigal-Pharmaceuticals-Announces-Support-of-Fatty-Liver-Foundation-s-Screening-Fund-to-Improve-Diagnosis-and-Staging-of-Non-Alcoholic-Fatty-Liver-Disease-NAFLD-and-Non-Alcoholic-.html Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Media name/outlet BizWire Express Country/Territory India Date 4/10/21 URL www.bizwireexpress.com/showstoryGNW.php?storyid=266091 Persons Meena Bansal Title Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH); In recognition of Liver Awareness Month, Madrigal Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 4/10/21 Persons Meena Bansal